Document Detail

Hetastarch as a prime for cardiopulmonary bypass.
MedLine Citation:
PMID:  6184024     Owner:  NLM     Status:  MEDLINE    
Hetastarch, a synthetic colloid osmotic plasma volume expander, was employed in a prime for cardiopulmonary bypass in 37 patients undergoing myocardial revascularization. Comparison of laboratory values to those of 42 patients undergoing myocardial revascularization using an albumin-containing prime showed lower postoperative platelet counts (p less than 0.02) with hetastarch. There were no differences in chest tube drainage, blood use, plasma hemoglobin, fibrinogen levels, of coagulation times. The hetastarch prime cost $119.50 per patient, whereas the albumin-containing prime cost $321.35 per patient.
D A Palanzo; G V Parr; A P Bull; D R Williams; M J O'Neill; J A Waldhausen
Related Documents :
18664784 - Leukocyte activation: the link between inflammation and coagulation during heatstroke. ...
8698274 - Thrombin-antithrombin iii complexes as an additional diagnostic aid in pulmonary embolism.
21412674 - Is activity loss predictive for development of upper limb oedema after stroke?
21180264 - An evaluation of the tuberculin skin test for anti tnf alpha prophylaxis in patients wi...
17205494 - The ulcerated leg severity assessment score for prediction of venous leg ulcer healing.
15207414 - Homocysteine in alzheimer disease and vascular dementia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  34     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1982 Dec 
Date Detail:
Created Date:  1983-01-19     Completed Date:  1983-01-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  680-3     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Albumins / administration & dosage
Cardiopulmonary Bypass*
Coronary Disease / surgery
Costs and Cost Analysis
Hetastarch* / administration & dosage
Middle Aged
Molecular Weight
Myocardial Revascularization / economics
Plasma Substitutes* / administration & dosage
Starch* / analogs & derivatives
Reg. No./Substance:
0/Albumins; 0/Plasma Substitutes; 9005-25-8/Starch; 9005-27-0/Hetastarch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical comparison of hetastarch and albumin in postoperative cardiac patients.
Next Document:  Univentricular heart: can we alter the natural history?